Histology and Cytology Market Growth, Demand and Challenges of the Key Industry Players 2024-2032
                     Global Histology and 
Cytology Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A c c o r d i n g  t o  t h e  l a t e s t  r e p o r t  b y  I M A R C  G r o u p ,  t i t l e d  " H i s t o l o g y  a n d  C y t o l o g y  M a r k e t :  
G lo b a l  I n d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  G r o w t h ,  O p p o r t u n i t y  a n d  F o r e c a s t  2 0 2 4 -
2 0 3 2 , "  t h e  g l o b a l  h i s t o l o g y  a n d  c y t o l o g y  m a r k e t  s i z e  r e a c h e d  U S $  1 6 .5  B i l l i o n  i n  2 0 2 3 .
F a c to rs  A f fe c t in g  th e  G ro w th  o f  th e  H is to lo g y  a n d  C y to lo g y  In d u s t ry :
A d v a n c e me n ts  in  D ia g n o s t ic  T e c h n o lo g ie s :
Report A d v a n c e m e n t s  i n  d i a g n o s t i c  t e c h n o l o g i e s  a r e  s i g n i f i c a n t l y  d r i v i n g  t h e  g l o b a l  h i s t o l o g y  a n d  
c y to l o g y  m a r k e t .  T h e  i n t e g r a t i o n  o f  a r t i f i c i a l  i n t e l l i g e n c e  ( A I )  a n d  m a c h i n e  l e a r n i n g  ( M L )  
i n t o  d i a g n o s t i c  p r o c e d u r e s  h a s  r e v o l u t i o n i z e d  t h e  f i e l d ,  e n h a n c i n g  t h e  a c c u r a c y  a n d  
Highlight and e f f i c i e n c y  o f  h i s t o l o g i c a l  a n d  c y to l o g i c a l  a n a l y s e s .  A I  a l g o r i t h m s  c a n  s w i f t l y  a n a l y z e  
c o m p l e x  p a t t e r n s  i n  t i s s u e  a n d  c e l l  s a m p l e s ,  p r o v i d i n g  r a p i d  a n d  p r e c i s e  d i a g n o s t i c s  t h a t  
s u r p a s s  t r a d i t i o n a l  m e t h o d s .  
Description A d d i t i o n a l l y ,  d i g i t a l  p a t h o l o g y ,  w h i c h  i n v o l v e s  t h e  a c q u i s i t i o n ,  m a n a g e m e n t ,  a n d  
i n t e r p r e t a t i o n  o f  p a th o l o g y  i n f o r ma t i o n  i n  a  d i g i t a l  e n v i r o n m e n t ,  h a s  g a i n e d  t r a c t i o n .  T h i s  
t e c h n o l o g y  a l l o w s  f o r  t h e  d i g i t i z a t i o n  o f  w h o l e  s l i d e  i m a g e s ,  e n a b l i n g  p a th o l o g i s t s  t o  
a n a l y z e  s a m p l e s  r e m o t e l y  a n d  c o l l a b o r a t e  g l o b a l l y .  F u r t h e r m o r e ,  i n n o v a t i o n s  i n  m o l e c u l a r  
d i a g n o s t i c s ,  s u c h  a s  n e x t - g e n e r a t i o n  s e q u e n c i n g  ( N G S )  a n d  p o l y m e r a s e  c h a i n  r e a c t i o n  
( P C R ) ,  h a v e  i m p r o v e d  t h e  d e t e c t i o n  a n d  c h a r a c te r i z a t i o n  o f  g e n e t i c  a l t e r a t i o n s  i n  c a n c e r  
a n d  o t h e r  d i s e a s e s .
Increas ing  Inc idence  o f  Cancer  and Chron ic  D iseases:
T he  r i s i n g  i n c i d e n c e  o f  c a n c e r  a nd  c h ro n i c  d i s e a s es  i s  a  c r i t i c a l  f a c to r  p r o p e l l i ng  t he  
g r o w t h  o f  t h e  h i s t o l o g y  a n d  c y t o l og y  ma r k e t .  C a n c e r  r em a i n s  o n e  o f  t he  l e ad i n g  c a u se s  
o f  m o r b i d i t y  a nd  m o r t a l i t y  w o r l d w i d e ,  w i t h  m i l l i o ns  o f  n e w  c a s e s  d i a gn o s e d  e a c h  y e a r .  
T he  i n c r e a s i ng  p r ev a l e n c e  o f  c a n c e r  c a n  b e  a t t r i bu t e d  t o  v a r i o u s  f a c t o rs ,  i n c l u d i n g  
Report ag i ng  p o pu l a t i o n s ,  l i f e s t y l e  ch a n g es ,  a nd  e nv i r o n me n t a l  i n f l u e n ce s .  E a r l y  a n d  a cc u r a t e  
d i a gn o s i s  i s  c r u c i a l  f o r  e f f e c t i v e  c a n ce r  t r e a t m en t  an d  m an a g e me n t ,  w h i c h  u n d e rs c o re s  
Highlight and t he  i m po r t a n ce  o f  h i s t o l o g i c a l  a n d  c y t o l og i c a l  t ec h n i q u es .  T he s e  te c h n i qu e s  a r e  e s se n t i a l  f o r  d e t e c t i ng  c a nc e r o u s  c h a ng e s  i n  t i s s u e s  a n d  c e l l s ,  
gu i d i n g  t re a t m en t  d e c i s i o n s ,  a n d  mo n i t o r i ng  d i s ea s e  p r o g r es s i o n .  M o r eo v e r ,  c h r on i c  
Description d i se a s e s  s u ch  a s  c a r d i ov a s cu l a r  d i s e as e s ,  d i a b e t e s ,  a nd  a u t o i m mu n e  d i so r d e r s  a l s o  d r i v e  th e  d em a n d  f o r  h i s to l o g y  a n d  c y t o l o g y  se r v i c e s .  T h e s e  c on d i t i o n s  o f te n  r e q u i re  
t i s su e  a nd  c e l l  an a l y s i s  f o r  d i a g n o s i s ,  t r ea t m e n t  p l a nn i n g ,  a nd  m on i t o r i n g .
Government  In i t ia t ives  and Fund ing fo r  Cancer  Research:
Go v e r nm e n t  i n i t i a t i v e s  a nd  fu n d i n g  fo r  c a n ce r  r e s ea r c h  p l ay  a  p i v o t a l  r o l e  i n  d r i v i n g  
t he  h i s t o l o g y  an d  c y t o l o g y  m a r ke t .  Go v e r nm e n ts  w o r l dw i d e  r e c o g n i z e  t h e  s i g n i f i c a n t  
he a l t h  a n d  ec o n o m i c  i m p ac t s  o f  c a n c e r  a n d  o th e r  c h r o n i c  d i s ea s e s ,  l e a d i n g  to  
i n c r e a s e d  i n v e s tm e n t s  i n  re s e a r c h  a n d  h e a l t h ca r e  i n f r a s t r uc t u re .
Substan t ia l  fund ing  is  a l loca ted  to  cance r  research  ins t i t u tes ,  academic  
ins t i tu t ions ,  and  b io techno logy  compan ies  to  deve lop  innova t i ve  d iagnos t ic  
and  the rapeu t i c  so lu t ions .  For  i ns tance ,  na t iona l  cance r  ins t i tu tes  and  
o rgan iza t ions  in  the  Un i ted  S ta tes ,  Eu rope ,  and  As ia  rece ive  subs tan t ia l  
g ran ts  to  suppor t  research  in  cancer  b io logy ,  ea r ly  de tec t ion ,  and  t rea tment .  
These  in i t i a t i ves  o f ten  inc lude  fund ing  fo r  t he  deve lopmen t  and  improvement  
Report o f  h is to log ica l  and  cy to log ica l  t echn iques,  p romot ing  techno log ica l  advancements  and  improv ing  d iagnos t i c  accuracy .
Highlight and Request  for  a  PDF sample  o f  th is  repor t :  
h t tps : / /www. imarcgroup .com/h is to logy-cy to logy-marke t / reques tsamp le
Description
Report Description
Global Histology and Cytology Market Trends:
The growing ger ia t r ic  popula t ion is  a  s ign i f icant  dr iver  o f  the h is to logy and cyto logy market .  As 
ind iv iduals  age,  they become more suscept ib le  to  var ious d iseases,  inc lud ing cancer  and chron ic  
condi t ions that  requi re  d iagnost ic  and moni tor ing serv ices.  The e lder ly  popula t ion of ten exper iences 
an increase in  the inc idence of  cancer ,  card iovascular  d iseases,  and degenerat ive d isorders,  
necessi ta t ing f requent h isto log ica l  and cyto log ica l  examinat ions.  
 Ag ing populat ions in  deve loped countr ies,  and increasingly in  develop ing reg ions,  cont r ibute to  the 
he ightened demand for  these d iagnost ic  serv ices.  Wi th  advancements in  heal thcare pro longing l i fe  
expectancy,  the need for  cont inuous and comprehensive d iagnost ic  care for  the ag ing demographic  
wi l l  cont inue to  expand, dr iv ing market  growth.
View Report  TOC, F igures and Tables :  ht tps: / /www.imarcgroup.com/histology-cytology-market
Breakup by Product:
• Instruments and Analysis Software System
• Consumable and Reagents
Breakup by Type of Examination:
• Histology
Report • Cytology
Segmentation
Breakup by Test Type:
• Microscopy Tests
• Molecular Genet ics Tests
• Flow Cytometry
Breakup by Application:
• Drug Discovery and Designing
• Clinical  Diagnostics
o Point -of-Care  (PoC)
o Non-Point-of-Care
Report • Research
Segmentation
Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Abbott Laboratories
• Becton Dickinson and Company
• Carl  Zeiss AG
• Danaher Corporation
Competitive • Hoff mann-La Roche AG
Landscape • Hologic Inc.
• Koninkl i jke Phi l ips N.V.
with Key 
• Merck KGaA
Players • Olympus Corporat ion
• PerkinElmer Inc.
• Sysmex Corporat ion
• Thermo Fisher Scient ifi c Inc.
• Triv itron Healthcare
What was the size of the global histology and 
cytology market in 2023?
What is the expected growth rate of the global 
histology and cytology market during 2024-2032?
Key 
What are the key factors driving the global 
Questions histology and cytology market?
Answered in 
What has been the impact of COVID-19 on the 
the Report global histology and cytology market?
What is the breakup of the global histology and 
cytology market based on the product?
What is the breakup of the global histology and 
cytology market based on the type of examination?
What is the breakup of the global histology and 
cytology market based on test type?
What is the breakup of the global histology and 
cytology market based on the application?
Key 
Questions What are the key regions in the global histology and cytology market?
Answered in 
Who are the key players/companies in the global 
the Report histology and cytology market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  H i s t o l o g y  a n d  C y t o l o g y  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t
    6 . 1     I n s t r u m e n t s  a n d  A n a l y s i s  S o f t w a r e  S y s t e m
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     C o n s u m a b l e  a n d  R e a g e n t s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  T y p e  o f  E x a m i n a t i o n
    7 . 1     H i s t o l o g y
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
       
    7 . 2     C y t o l o g y
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  T e s t  T y p e
    8 . 1     M i c r o s c o p y  T e s t s
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     M o l e c u l a r  G e n e t i c s  T e s t s
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     F l o w  C y t o m e t r y
        8 . 3 . 1  M a r k e t  T r e n d s
Table of         8 . 3 . 2  M a r k e t  F o r e c a s t9    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    9 . 1     D r u g  D i s c o v e r y  a n d  D e s i g n i n g
        9 . 1 . 1  M a r k e t  T r e n d s
Contents         9 . 1 . 2  M a r k e t  F o r e c a s t
    9 . 2     C l i n i c a l  D i a g n o s t i c s
        9 . 2 . 1  M a r k e t  T r e n d s
        9 . 2 . 2  K e y  S e g m e n t s
           9 . 2 . 2 . 1  P o i n t - o f - C a r e  ( P o C )
           9 . 2 . 2 . 2  N o n - P o i n t - o f - C a r e
        9 . 2 . 3  M a r k e t  F o r e c a s t
    9 . 3     R e s e a r c h
        9 . 3 . 1  M a r k e t  T r e n d s
        9 . 3 . 2  M a r k e t  F o r e c a s t
1 0   M a r k e t  B r e a k u p  b y  R e g i o n
    1 0 . 1     N o r t h  A m e r i c a
        1 0 . 1 . 1  U n i t e d  S t a t e s
           1 0 . 1 . 1 . 1  M a r k e t  T r e n d s
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /h i s to l o gy- c y to l o gy -ma rke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: